Sofinnova Partners and Gustave Roussy forge strategic alliance to boost oncology startup acceleration in France streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Villejuif, near Paris, France, November 30, 2021 – EverImmune, a biotechnology company specialized in the development of live biotherapeutic products in the field of microbiota oncology, today announces it has raised more than €5 million (approx. $6M) in a Series A funding from undisclosed private investors. EverImm.